While the company reports its initiatives are starting to pay off, its Q3 filings show several areas of financial strain.

Charles River Laboratories, a Wilmington, Mass., pharma services giant, is closing a Skokie office that will result in the ...

CLSA has recently initiated Charles River Lbrtrs ntrntl Inc (CRL) stock to Underperform rating, as announced on October 23, 2024, according to Finviz. Earlier, on October 14, 2024, Redburn Atlantic ...

Overall, analysts' consensus view on Charles River Laboratories stock is cautious ... As of writing, CRL is trading below the average analyst price target of $206.67. What to Expect From ...

In a report released on November 7, Patrick B Donnelly from Citi maintained a Sell rating on Charles River Labs (CRL – Research Report).

Charles River Laboratories International Inc CRL reported third-quarter 2024 revenue of $1.01 billion on Wednesday, a decrease of 1.6% year over year, beating the consensus of $976.02 million.

In a report released yesterday, Charles Rhyee from TD Cowen maintained a Hold rating on Charles River Labs (CRL – Research Report), with ...

Charles River provides essential products and services ... options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are ...

FibroBiologics has entered a master services agreement with Charles River Laboratories to develop and manufacture cell-based therapies for chronic diseases. The agreement will involve the ...